MEI Pharma Inc (MEIP) USD0.00000002

Sell:$5.24Buy:$5.25$0.12 (2.41%)

Prices delayed by at least 15 minutes
Sell:$5.24
Buy:$5.25
Change:$0.12 (2.41%)
Deal now
Prices delayed by at least 15 minutes
Sell:$5.24
Buy:$5.25
Change:$0.12 (2.41%)
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

MEI Pharma, Inc. is a pharmaceutical company with a portfolio of several drug candidates that may offer novel and differentiated therapies. The Company's treasury initiative is anchored by Litecoin. The Company has discontinued the clinical development of voruciclib, while certain nonclinical activities related to its drug candidate assets continue to be conducted by it. As part of the review of strategic alternatives, the Company may consider options such as out-licensing opportunities for existing programs and merger and acquisition opportunities.

Key people

Justin J. File
Acting Chief Executive Officer, Chief Financial Officer, Corporate Secretary
Frederick W. Driscoll
Independent Chairman of the Board
Nicholas R. Glover
Independent Director
Thomas C. Reynolds
Independent Director
Joshua Riezman
Independent Director
Click to see more

Key facts

  • EPIC
    MEIP
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    US55279B3015
  • Market cap
    $148.80m
  • Employees
    28
  • Shares in issue
    29.88m
  • Exchange
    NASDAQ
  • Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.